Phase II study of amsacrine and high-dose cytarabine for resistant acute myelogenous leukemia
(Q54400913)
scientific article
scientific article
Language:
Current Data About
Phase II study of amsacrine and high-dose cytarabine for resistant acute myelogenous leukemia